Avidity Biosciences, Inc. Common Stock (RNA)
Avidity Biosciences, Inc. is a biotechnology company focused on developing targeted RNA therapies using antibody-oligonucleotide conjugates. Their innovation aims to treat muscle and other diseases by delivering RNA-based therapeutics directly to specific tissues, leveraging their proprietary AOCs platform for precise and effective treatment options.
Company News
June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances. The technology sector, as tracked by the Technology Select Sector SPDR Fund (NYSE:XLK), led the 11 S&P 500 sectors in performance last month, surgin...
Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.
These two biotechnology stocks could be gearing up for a run.